Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.39 |
| ▸ | MLNR | O43193 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.37 |
| ▸ | ITGB1 | P05556 | 6/20 | 0.36 |
| ▸ | ITGA4 | P13612 | 6/20 | 0.36 |
| ▸ | ITGB2 | P05107 | 5/20 | 0.36 |
| ▸ | ITGA1 | P56199 | 4/20 | 0.36 |
| ▸ | ITGB7 | P26010 | 3/20 | 0.36 |
| ▸ | GABRA4 | P48169 | 3/20 | 0.36 |
| ▸ | ITGA5 | P08648 | 2/20 | 0.36 |
| ▸ | ITGAM | P11215 | 2/20 | 0.36 |
| ▸ | CTSD | P07339 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30038822 | 1.00 | HRH3 (0.39) | HRH3MLNRMEN1ALDH1A1KMT2A | |
| SCHEMBL2869111 | 1.00 | HRH3 (0.39) | HRH3MLNRMEN1ALDH1A1KMT2A | |
| SCHEMBL30436539 | 1.00 | HRH3 (0.39) | HRH3MLNRMEN1ALDH1A1KMT2A | |
| SCHEMBL29822681 | 0.93 | MLNR (0.38) | HRH3MLNRMEN1ALDH1A1KMT2A | |
| Chrysosporide SCHEMBL30609551 | 0.91 | ITGB1 (0.43) | HRH3MLNRHDAC1ITGB1ITGA4 | |
| SCHEMBL29885671 | 0.90 | PSMB11 (0.38) | HRH3MLNRMEN1ALDH1A1KMT2A | |
| SCHEMBL163425 | 0.87 | MEN1 (0.41) | MEN1KMT2A | |
| SCHEMBL2867325 | 0.87 | MEN1 (0.41) | MEN1KMT2A | |
| SCHEMBL14952770 | 0.85 | MEN1 (0.33) | MLNRMEN1ALDH1A1KMT2AMAPT | |
| SCHEMBL6989670 | 0.84 | HDAC3 (0.50) | HRH3MLNRHDAC1ITGB1ITGA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8765309-B2 | Electrochemical device | KONICA MINOLTA HOLDINGS, INC. (JP) | 2014-07-01 | — | — | US | disclosed |
| US-8765309-B2 | Electrochemical device | KONICA MINOLTA HOLDINGS, INC. (JP) | 2014-07-01 | — | — | US | disclosed |
| US-8269024-B2 | Compounds and methods for modulating communication and virulence in quorum sensing bacteria | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2012-09-18 | — | — | US | disclosed |
| US-8269024-B2 | Compounds and methods for modulating communication and virulence in quorum sensing bacteria | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2012-09-18 | — | — | US | disclosed |
| US-20110143211-A1 | ELECTROCHEMICAL DEVICE | KONICA MINOLTA HOLDINGS, INC. (JP) | 2011-06-16 | — | — | US | disclosed |
| US-20110143211-A1 | ELECTROCHEMICAL DEVICE | KONICA MINOLTA HOLDINGS, INC. (JP) | 2011-06-16 | — | — | US | disclosed |
| US-20100305182-A1 | COMPOUNDS AND METHODS FOR MODULATING COMMUNICATION AND VIRULENCE IN QUORUM SENSING BACTERIA | BLACKWELL HELEN E | 2010-12-02 | — | — | US | disclosed |
| US-20100305182-A1 | COMPOUNDS AND METHODS FOR MODULATING COMMUNICATION AND VIRULENCE IN QUORUM SENSING BACTERIA | BLACKWELL HELEN E | 2010-12-02 | — | — | US | disclosed |
| US-7642285-B2 | Compounds and methods for modulating communication and virulence in quorum sensing bacteria | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2010-01-05 | — | — | US | disclosed |
| US-7642285-B2 | Compounds and methods for modulating communication and virulence in quorum sensing bacteria | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2010-01-05 | — | — | US | disclosed |
| US-20050077648-A1 | Solution casting method and polymer film | FUJIFILM CORPORATION (JP) | 2005-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100305182-A1 | COMPOUNDS AND METHODS FOR MODULATING COMMUNICATION AND VIRULENCE IN QUORUM SENSING BACTERIA | AHCYL1, BPHL, AIP | HRH3 2046/4885MLNR 2233/4885MEN1 1929/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.